Closed-angle Glaucoma:
500mg PO/IV, followed by 125-250mg PO q4h
500mg PO q12h (sustained release)
Open-angle Glucoma:
250mg-1g PO/IV QD
500mg PO q12h (sustained release)
500mg PO/IV, followed by 125-250mg PO q4h
500mg PO q12h (sustained release)
250mg-1g PO/IV QD
500mg PO q12h (sustained release)
500-1000mg extended release PO QD
Continue treatment for 48 hours or longer if necessary
125mg PO BID
Start 24hr before ascent and continue for the first 48hrs at peak altitude
250-375mg PO qAM
5mg/kg
250-375mg PO qAM
8-30mg/kg/day PO QD
Do not exceed 30mg/kg/day or 1g/day
Familial periodic paralysis; Hydrocephalus, normal-pressure; Idiopathic intracranial hypertension; Metabolic alkalosis; Prevention of cystine renal calculi (adjunctive therapy); Respiratory stimulant in stable hypercapnic COPD
Acetazolamide
Mannitol
Timolol
Tropicamide
Ventriculoperitoneal shunt drainage
Amiloride
Epoprostenol 
Clevidipine